Two-tower project at 1445 120th Avenue NE receives environmental approval as part of larger Pine Forest campus transformation The shift from traditional office...
ByThe RegistryOctober 16, 2025New York Developer’s $81 Million Gamble on Elliott Avenue Property Tests Office-to-Residential Strategy in Pacific Northwest When Vanbarton Group acquired the hulking former...
ByThe RegistrySeptember 24, 2025By The Registry Staff One of Seattle’s newest life science properties is now on the market. The asset at 222 Fifth Ave. N,...
ByThe RegistrySeptember 17, 2025A significant office development poised to reshape a prominent corner of downtown Bellevue, the KANON project by Beam Reach Partners, continues its journey...
ByThe RegistryJuly 30, 2025A historic Seattle office complex that once housed the headquarters of online retailer Zulily is poised for a dramatic transformation into luxury apartments...
ByThe RegistryJuly 15, 2025By Kate Snyder With proposals throughout the United States to sell official buildings as part of an effort to cut costs and refine...
ByThe RegistryMarch 28, 2025State-of-the-Art Building Scheduled for Delivery in Fall 2025 SEATTLE (Feb. 18, 2025) — Mortenson, in partnership with the University of Washington, Gensler, Holmes, and...
ByThe RegistryFebruary 18, 2025Seattle, WA—Located adjacent to the iconic Seattle Center, 222 Fifth is a 9-story, 200,000-square-foot, cutting-edge research and development (R&D) building that prioritizes flexibility,...
ByThe RegistryJanuary 7, 2025With the release of its 2025 Design Forecast, global architecture and design firm Gensler offers a forward-looking blueprint for shaping the future of...
ByThe RegistryDecember 18, 2024The University of Washington, in partnership with Integrated Design-Build partners Mortenson and Gensler, broke ground on the University of Washington’s new ICA Basketball...
ByThe RegistryAugust 20, 2024This article contains affiliate links. We may earn a commission if you make a purchase through these links, at no extra cost to...
ByThe RegistryAugust 8, 2024By The Registry Staff Seattle-based Bonum Therapeutics, a rising star in the biotechnology sector, is set to double its current footprint in August...
ByThe RegistryJuly 22, 2024
Signup for news and special announcements!
You have successfully joined our subscriber list.